- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01059760
Expression of Longevity Genes in Response to Extended Fasting (FEELGOOD)
2017년 4월 18일 업데이트: Intermountain Health Care, Inc.
The purpose of this study is to evaluate the effect of fasting on physical changes associated with cardiovascular disease.
연구 개요
상세 설명
Coronary heart disease (CHD) is the largest contributor to morbidity and mortality in the Western world and is associated with high-calorie diet, high body mass, and a variety of other factors.
CHD can lead to myocardial infarction (MI) and other embolic events.
A growing body of evidence suggests that relatively low caloric intake in the diets of a variety of animals increases longevity and preliminary evidence among humans indicates that such caloric restriction reduces risk factors for CHD, including cholesterol levels, blood pressure, glucose, and obesity.
Caloric restriction has also been shown to alter the expression of certain genes, especially the forkhead box (FOX) O and sirtuin (SIRT) genes whose over-expression has been shown to increase longevity in animal models.
Extended avoidance of caloric intake, also called fasting or short-term starvation, has been shown to increase expression of the FOXA genes that have similar sequence and function as the FOXO genes and that have been shown to increase longevity among animals regardless of FOXO function.
We recently demonstrated that the risk of CHD was significantly lower among patients who reported a history of routine periodic extended fasting.
The two primary hypotheses for this observation are that fasting may improve individual ability to control dietary intake or that fasting may initiate a cascade of protective mechanisms that preserve cellular and metabolic health.
연구 유형
중재적
등록 (실제)
30
단계
- 해당 없음
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 장소
-
-
Utah
-
Murray, Utah, 미국, 84107-5701
- Intermountain Medical Center
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
18년 (성인, 고령자)
건강한 자원 봉사자를 받아들입니다
예
연구 대상 성별
모두
설명
Inclusion Criteria:
- The volunteer (male or non-pregnant female, any ethnicity) must be >18 years of age.
- The volunteer must either have a body mass index of 25.0-35.0 kg/m2 or the combination of a body mass index of 18.5-24.9 kg/m2 and two or more previously or currently measured symptoms of the metabolic syndrome (fasting glucose≥110 mg/dL, triglycerides≥150 mg/dL, high-density lipoprotein cholesterol<40 mg/dL in males or <50 mg/dL in females, systolic blood pressure≥130 mmHg or diastolic blood pressure≥85 mmHg, or waist circumference≥40 inches in males or ≥36 inches in females [glucose and cholesterol levels may be self-reported]).
- The volunteer has not routinely participated in caloric restriction (deliberate limitation of caloric intake of <80% than the FDA-recommended daily caloric intake) within the last 2 years, has not participated in extended fasting (>12 hours at a time) for at least a year, and does not deliberately skip meals as a routine dietary practice.
Exclusion Criteria:
- Body mass index <18.5 or >35 kg/m2.
- Current active cancer treatment, treatment with immunosuppressive medications, or solid organ transplantation within 1 year.
- Presence of immunosuppressive disease, myocardial infarction, peripheral vascular disease, or stroke within the past year.
- Use of insulin.
- Although it is unlikely fasting will harm the pregnant or lactating woman, the dietary restrictions placed on the participant for the duration of the study may conflict with dietary recommendations for pregnant or lactating women. Women of child bearing potential, therefore, will meet an exclusion if they become pregnant.
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
다른: Fasting Day First
28±4 hours of water-only fasting followed by 28±4 hours fed
|
28±4 hours of water-only fasting followed by 28±4 hours fed
|
다른: Fed Day First
28± 4 hours fed followed by 28± 4 hours of fasting
|
28± 4 hours fed followed by 28± 4 hours of fasting
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Change From Baseline in Participant Glucose When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Human Growth Hormone (HGH) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Insulin When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) When Fasting and Fed
기간: Baseline and 3 days
|
HOMA-IR is used to measure the severity of insulin resistance.
Healthy Range: 1.0 (0.5-1.4) Less than 1.0 is optimal Above 1.9 indicates early insulin resistance Above 2.9 indicates significant insulin resistance
|
Baseline and 3 days
|
Change From Baseline in Participant Glycogen-Like Protein-1 (GLP-1) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Adiponectin When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Fibroblast Growth Factor-21 (FGF-21) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant White Blood Cell Count (WBC) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Hemoglobin When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Red Blood Cell Count (RBC) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Hematocrit When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Platelet Count When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Mean Corpuscular Volume (MCV) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Mean Corpuscular Hemoglobin (MCH) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Mean Corpuscular Hemoglobin Concentration (MCHC) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Red Cell Distribution Width (RDW) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Mean Platelet Volume (MPV) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Bicarbonate When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Sodium When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Chloride When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Blood Urea Nitrogen (BUN) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Calcium When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Potassium When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Creatinine When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Total Cholesterol (TC) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Low-Density Lipoprotein Cholesterol (LDL-C) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant High-Density Lipoprotein Cholesterol (HDL-C) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Triglycerides When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant TC/HDL Ratio When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Weight When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Waist Circumference When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Systolic Blood Pressure (SBP), Supine When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant Diastolic Blood Pressure (DBP), Supine When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
|
Change From Baseline in Participant High Sensitivity C-Reactive Protein (hsCRP) When Fasting and Fed
기간: Baseline and 3 days
|
Baseline and 3 days
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
수사관
- 수석 연구원: Benjamin D Horne, PhD, Intermountain Medical Center
간행물 및 유용한 링크
연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.
일반 간행물
- Allaf M, Elghazaly H, Mohamed OG, Fareen MFK, Zaman S, Salmasi AM, Tsilidis K, Dehghan A. Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013496. doi: 10.1002/14651858.CD013496.pub2.
- Horne BD, May HT, Anderson JL, Kfoury AG, Bailey BM, McClure BS, Renlund DG, Lappe DL, Carlquist JF, Fisher PW, Pearson RR, Bair TL, Adams TD, Muhlestein JB; Intermountain Heart Collaborative Study. Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol. 2008 Oct 1;102(7):814-819. doi: 10.1016/j.amjcard.2008.05.021. Epub 2008 Jul 10.
- Horne BD, Muhlestein JB, Lappe DL, May HT, Carlquist JF, Galenko O, Brunisholz KD, Anderson JL. Randomized cross-over trial of short-term water-only fasting: metabolic and cardiovascular consequences. Nutr Metab Cardiovasc Dis. 2013 Nov;23(11):1050-7. doi: 10.1016/j.numecd.2012.09.007. Epub 2012 Dec 7.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작
2010년 1월 1일
기본 완료 (실제)
2010년 8월 1일
연구 완료 (실제)
2010년 10월 1일
연구 등록 날짜
최초 제출
2010년 1월 28일
QC 기준을 충족하는 최초 제출
2010년 1월 29일
처음 게시됨 (추정)
2010년 2월 1일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2017년 7월 17일
QC 기준을 충족하는 마지막 업데이트 제출
2017년 4월 18일
마지막으로 확인됨
2011년 3월 1일
추가 정보
이 연구와 관련된 용어
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Fasting First에 대한 임상 시험
-
University Hospital, Basel, SwitzerlandLondon School of Hygiene and Tropical Medicine; Swiss National Science Foundation; Swiss... 그리고 다른 협력자들모집하지 않고 적극적으로
-
Foundation for Innovative New Diagnostics, SwitzerlandMinistry of Health, Malaysia; Hospital Sultanah Bahiyah; Malaysian AIDS Council모병
-
Menzies School of Health ResearchCharles Darwin University; Northern Territory of Australia as represented by the Department... 그리고 다른 협력자들모병
-
Midatech Pharma US Inc.PharPoint Research, Inc.종료됨